The Heartpod Implantable Heart Failure Therapy System - 18/08/11
, Henry Krum, MBBS, FRACP, PhD
Corresponding author. Tel.: +61 3 9426 6693; fax: +61 3 9429 5563.Résumé |
Congestive heart failure has been described as the new epidemic, despite advances in drug therapy a 2-year mortality of up to 50% persists. This is despite recent improvements in drug therapy. There are limitations to the current drug treatments and cardiac resynchronization devices. The treatment of diastolic dysfunction can be suboptimal. The Savacor Company developed the Heartpod device to directly measure left atrial pressure in patients with congestive heart failure via an implantable device. The patient can in real time, download their intra-cardiac pressure measurements to a hand-held device. With this information, they can titrate their own treatment in a very precise manner.
Le texte complet de cet article est disponible en PDF.Plan
Vol 14 - N° 2S
P. S31-S33 - 2005 Retour au numéro
Article précédent
- Nuclear Cardiology
- Zita E. Ballok
- Epworth Hospital Electrophysiology and Pacing Report, 2004–2005
- Michael A. Jones
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?